
The acquisition brings Gallant’s experimental stem cell treatments for chronic gingivostomatitis and osteoarthritis in dogs and cats into Dechra’s portfolio.
Participants in the 2011 Bayer Veterinary Care Usage Study were asked whether they agreed with the following statements about using the Internet for their pet health needs:

